Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -7,627 | -2,178 | -7,208 | -13,564 |
| Depreciation Amortization | N/A | 2 | 97 | 110 |
| Accounts payable and accrued liabilities | 189 | -445 | N/A | N/A |
| Other Working Capital | 854 | -319 | -81 | -1,311 |
| Other Operating Activity | 179 | 750 | 1,368 | 4,222 |
| Operating Cash Flow | $-6,405 | $-2,190 | $-5,824 | $-10,543 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -98 | -5 | 0 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -1,000 |
| Investing Cash Flow | $-98 | $-5 | $0 | $-1,000 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 82,941 | 0 | 0 | 225 |
| Financing Cash Flow | $82,941 | $N/A | $0 | $225 |
| Beginning Cash Position | 9,735 | 9,735 | 15,559 | 26,877 |
| End Cash Position | 86,173 | 7,540 | 9,735 | 15,559 |
| Net Cash Flow | $76,438 | $-2,195 | $-5,824 | $-11,318 |
| Free Cash Flow | ||||
| Operating Cash Flow | -6,405 | -2,190 | -5,824 | -10,543 |
| Capital Expenditure | -98 | -5 | N/A | N/A |
| Free Cash Flow | -6,503 | -2,195 | -5,824 | -10,543 |